Study of IMP4297 in Patients With BRCA1/2 Mutation Ovarian Cancer
Clinical trial NCT04089189 · COMPLETED
Trial details
- NCT number
- NCT04089189
- Sponsor
- Impact Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-28
- Primary completion
- 2023-06-30
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.